| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 1.22e-05 | 14 | 216 | 4 | GO:0140333 | |
| GeneOntologyMolecularFunction | flippase activity | 2.84e-05 | 17 | 216 | 4 | GO:0140327 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 3.52e-05 | 35 | 216 | 5 | GO:0015020 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | SGSM1 MYCBP2 MCF2L2 OBSCN RASA4B GNAQ HERC2 HERC1 PSD3 ARHGEF10L ARHGEF33 RASA4 DEF6 ARHGAP28 RIMS1 ARHGAP45 | 1.36e-04 | 507 | 216 | 16 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | SGSM1 MYCBP2 MCF2L2 OBSCN RASA4B GNAQ HERC2 HERC1 PSD3 ARHGEF10L ARHGEF33 RASA4 DEF6 ARHGAP28 RIMS1 ARHGAP45 | 1.36e-04 | 507 | 216 | 16 | GO:0030695 |
| GeneOntologyMolecularFunction | complement component C1q complex binding | 1.42e-04 | 10 | 216 | 3 | GO:0001849 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 2.22e-04 | 28 | 216 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 2.22e-04 | 28 | 216 | 4 | GO:0140326 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | PRTG SPTAN1 OBSCN ITGA2 ITGAD ITGAE EPS15L1 NRXN3 DST PTPRF NECTIN1 DSC2 KTN1 AHSA1 NISCH CCT8 CDH9 | 2.94e-04 | 599 | 216 | 17 | GO:0050839 |
| GeneOntologyMolecularFunction | DNA-dependent protein kinase activity | 3.47e-04 | 3 | 216 | 2 | GO:0004677 | |
| GeneOntologyMolecularFunction | histone H3K9 acetyltransferase activity | 3.47e-04 | 3 | 216 | 2 | GO:0043992 | |
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 3.47e-04 | 3 | 216 | 2 | GO:0035979 | |
| GeneOntologyMolecularFunction | floppase activity | 6.30e-04 | 16 | 216 | 3 | GO:0140328 | |
| GeneOntologyMolecularFunction | steroid 21-monooxygenase activity | 6.89e-04 | 4 | 216 | 2 | GO:0004509 | |
| GeneOntologyMolecularFunction | progesterone 21-hydroxylase activity | 6.89e-04 | 4 | 216 | 2 | GO:0106309 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | SGSM1 GAPDH MYCBP2 MCF2L2 OBSCN NLRC4 WASH6P KAT2B RASA4B C4A C4B GNAQ HERC2 HERC1 VIL1 COL6A3 UGT1A10 UGT1A8 UGT1A7 PSD3 UGT1A9 ARHGEF10L ARHGEF33 RASA4 PEBP1 DEF6 ARHGAP28 RIMS1 ARHGAP45 | 6.97e-04 | 1418 | 216 | 29 | GO:0030234 |
| GeneOntologyMolecularFunction | protein kinase C binding | 7.40e-04 | 66 | 216 | 5 | GO:0005080 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | TDRD9 APTX TRPM2 ATP10B GSPT2 ATP11C ATP11A GNAQ TAP2 RAB25 RHOBTB3 NKIRAS2 ATP8B2 PLPP6 DNAH12 CHTF18 DDX25 CCT8 DHX32 SEPTIN10 | 8.16e-04 | 839 | 216 | 20 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | TDRD9 APTX TRPM2 ATP10B GSPT2 ATP11C ATP11A GNAQ TAP2 RAB25 RHOBTB3 NKIRAS2 ATP8B2 PLPP6 DNAH12 CHTF18 DDX25 CCT8 DHX32 SEPTIN10 | 8.28e-04 | 840 | 216 | 20 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | TDRD9 APTX TRPM2 ATP10B GSPT2 ATP11C ATP11A GNAQ TAP2 RAB25 RHOBTB3 NKIRAS2 ATP8B2 PLPP6 DNAH12 CHTF18 DDX25 CCT8 DHX32 SEPTIN10 | 8.28e-04 | 840 | 216 | 20 | GO:0016818 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | MYCBP2 MCF2L2 OBSCN HERC2 HERC1 PSD3 ARHGEF10L ARHGEF33 DEF6 | 9.57e-04 | 231 | 216 | 9 | GO:0005085 |
| GeneOntologyMolecularFunction | farnesyltranstransferase activity | 1.14e-03 | 5 | 216 | 2 | GO:0004311 | |
| GeneOntologyMolecularFunction | phosphatidylserine flippase activity | 1.14e-03 | 5 | 216 | 2 | GO:0140346 | |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 1.14e-03 | 5 | 216 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | threonine-type peptidase activity | 1.24e-03 | 20 | 216 | 3 | GO:0070003 | |
| GeneOntologyMolecularFunction | phosphatidylcholine flippase activity | 1.70e-03 | 6 | 216 | 2 | GO:0140345 | |
| GeneOntologyMolecularFunction | retinoid binding | 1.79e-03 | 48 | 216 | 4 | GO:0005501 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 5.48e-08 | 5 | 213 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 1.63e-07 | 6 | 213 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 1.63e-07 | 6 | 213 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 1.63e-07 | 6 | 213 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 2.21e-06 | 10 | 213 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 2.21e-06 | 10 | 213 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 6.18e-06 | 26 | 213 | 5 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 6.18e-06 | 26 | 213 | 5 | GO:0006063 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 7.35e-06 | 13 | 213 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 1.07e-05 | 5 | 213 | 3 | GO:0052696 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 5.76e-05 | 21 | 213 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 5.76e-05 | 21 | 213 | 4 | GO:0042447 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 1.08e-05 | 14 | 219 | 4 | GO:1990531 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 5.95e-05 | 94 | 219 | 7 | GO:0044291 | |
| Domain | UDPGT | 3.23e-06 | 21 | 213 | 5 | PF00201 | |
| Domain | UDPGT | 3.23e-06 | 21 | 213 | 5 | PS00375 | |
| Domain | UDP_glucos_trans | 3.23e-06 | 21 | 213 | 5 | IPR002213 | |
| Domain | P_typ_ATPase_c | 1.51e-05 | 14 | 213 | 4 | IPR032630 | |
| Domain | P-type_ATPase_N | 1.51e-05 | 14 | 213 | 4 | IPR032631 | |
| Domain | P-type_ATPase_IV | 1.51e-05 | 14 | 213 | 4 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 1.51e-05 | 14 | 213 | 4 | PF16212 | |
| Domain | PhoLip_ATPase_N | 1.51e-05 | 14 | 213 | 4 | PF16209 | |
| Domain | SPEC | 2.88e-05 | 32 | 213 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.88e-05 | 32 | 213 | 5 | IPR018159 | |
| Domain | VWA | 4.14e-05 | 56 | 213 | 6 | PF00092 | |
| Domain | Spectrin | 1.23e-04 | 23 | 213 | 4 | PF00435 | |
| Domain | Hist_acetylase_PCAF | 1.29e-04 | 2 | 213 | 2 | IPR016376 | |
| Domain | PCAF_N | 1.29e-04 | 2 | 213 | 2 | IPR009464 | |
| Domain | SPIN-2 | 1.29e-04 | 2 | 213 | 2 | IPR029564 | |
| Domain | PCAF_N | 1.29e-04 | 2 | 213 | 2 | PF06466 | |
| Domain | Spectrin_repeat | 3.12e-04 | 29 | 213 | 4 | IPR002017 | |
| Domain | VWFA | 3.49e-04 | 82 | 213 | 6 | PS50234 | |
| Domain | Aminotrans_V_PyrdxlP_BS | 3.85e-04 | 3 | 213 | 2 | IPR020578 | |
| Domain | - | 3.85e-04 | 3 | 213 | 2 | 4.10.1130.10 | |
| Domain | VWA | 3.98e-04 | 84 | 213 | 6 | SM00327 | |
| Domain | - | 4.60e-04 | 32 | 213 | 4 | 3.40.1110.10 | |
| Domain | - | 4.60e-04 | 32 | 213 | 4 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 6.53e-04 | 35 | 213 | 4 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 7.28e-04 | 36 | 213 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 7.28e-04 | 36 | 213 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 7.28e-04 | 36 | 213 | 4 | PS00154 | |
| Domain | Integrin_alpha_C_CS | 7.34e-04 | 16 | 213 | 3 | IPR018184 | |
| Domain | LamGL | 7.65e-04 | 4 | 213 | 2 | SM00560 | |
| Domain | LamG-like | 7.65e-04 | 4 | 213 | 2 | IPR006558 | |
| Domain | ATPase_P-typ_transduc_dom_A | 8.09e-04 | 37 | 213 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 8.09e-04 | 37 | 213 | 4 | PF00122 | |
| Domain | ConA-like_dom | 9.48e-04 | 219 | 213 | 9 | IPR013320 | |
| Domain | VWF_A | 9.52e-04 | 99 | 213 | 6 | IPR002035 | |
| Domain | Integrin_alpha-2 | 1.05e-03 | 18 | 213 | 3 | IPR013649 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 1.05e-03 | 18 | 213 | 3 | IPR008930 | |
| Domain | INTEGRIN_ALPHA | 1.05e-03 | 18 | 213 | 3 | PS00242 | |
| Domain | Integrin_alpha2 | 1.05e-03 | 18 | 213 | 3 | PF08441 | |
| Domain | Integrin_alpha | 1.05e-03 | 18 | 213 | 3 | IPR000413 | |
| Domain | Int_alpha | 1.24e-03 | 19 | 213 | 3 | SM00191 | |
| Domain | Int_alpha_beta-p | 1.24e-03 | 19 | 213 | 3 | IPR013519 | |
| Domain | AA_TRANSFER_CLASS_5 | 1.27e-03 | 5 | 213 | 2 | PS00595 | |
| Domain | Anaphylatoxin_comp_syst | 1.27e-03 | 5 | 213 | 2 | IPR018081 | |
| Domain | Glyco_hydro_38_C | 1.27e-03 | 5 | 213 | 2 | IPR011682 | |
| Domain | Alpha-mann_mid | 1.27e-03 | 5 | 213 | 2 | PF09261 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.27e-03 | 5 | 213 | 2 | IPR001840 | |
| Domain | Glyco_hydro_57/38_cen | 1.27e-03 | 5 | 213 | 2 | IPR028995 | |
| Domain | SPIN/Ssty | 1.27e-03 | 5 | 213 | 2 | IPR003671 | |
| Domain | Autophagy-rel_C | 1.27e-03 | 5 | 213 | 2 | IPR015412 | |
| Domain | Glyco_hydro_38 | 1.27e-03 | 5 | 213 | 2 | PF01074 | |
| Domain | ATG_C | 1.27e-03 | 5 | 213 | 2 | PF09333 | |
| Domain | - | 1.27e-03 | 5 | 213 | 2 | 1.20.1270.50 | |
| Domain | - | 1.27e-03 | 5 | 213 | 2 | 3.20.110.10 | |
| Domain | Alpha-mann_mid | 1.27e-03 | 5 | 213 | 2 | SM00872 | |
| Domain | Spin-Ssty | 1.27e-03 | 5 | 213 | 2 | PF02513 | |
| Domain | Glyco_hydro_38_N | 1.27e-03 | 5 | 213 | 2 | IPR000602 | |
| Domain | Glyco_hydro_38/57_N | 1.27e-03 | 5 | 213 | 2 | IPR027291 | |
| Domain | FATC | 1.27e-03 | 5 | 213 | 2 | PF02260 | |
| Domain | Glyco_hydro_38_cen | 1.27e-03 | 5 | 213 | 2 | IPR015341 | |
| Domain | Glyco_hydro_38C | 1.27e-03 | 5 | 213 | 2 | PF07748 | |
| Domain | RCC1 | 1.44e-03 | 20 | 213 | 3 | PF00415 | |
| Domain | IGc2 | 1.55e-03 | 235 | 213 | 9 | SM00408 | |
| Domain | Ig_sub2 | 1.55e-03 | 235 | 213 | 9 | IPR003598 | |
| Domain | Ig_I-set | 1.55e-03 | 190 | 213 | 8 | IPR013098 | |
| Domain | I-set | 1.55e-03 | 190 | 213 | 8 | PF07679 | |
| Domain | - | PRTG MYCBP2 OBSCN HEPACAM2 PTPRF NFKB1 NECTIN1 ALPK3 USH2A PLXNA2 COL6A3 SDK2 PKHD1L1 SEMA4G LRIG3 SEMA3D CNTN3 | 1.61e-03 | 663 | 213 | 17 | 2.60.40.10 |
| Domain | RCC1_1 | 1.67e-03 | 21 | 213 | 3 | PS00625 | |
| Domain | RCC1_2 | 1.67e-03 | 21 | 213 | 3 | PS00626 | |
| Domain | RCC1_3 | 1.67e-03 | 21 | 213 | 3 | PS50012 | |
| Domain | PbH1 | 1.88e-03 | 6 | 213 | 2 | SM00710 | |
| Domain | Aminotrans_V_dom | 1.88e-03 | 6 | 213 | 2 | IPR000192 | |
| Domain | EFhand_Ca_insen | 1.88e-03 | 6 | 213 | 2 | PF08726 | |
| Domain | EF-hand_Ca_insen | 1.88e-03 | 6 | 213 | 2 | IPR014837 | |
| Domain | FAT | 1.88e-03 | 6 | 213 | 2 | PS51189 | |
| Domain | FATC | 1.88e-03 | 6 | 213 | 2 | PS51190 | |
| Domain | CPSASE_2 | 1.88e-03 | 6 | 213 | 2 | PS00867 | |
| Domain | FAT | 1.88e-03 | 6 | 213 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 1.88e-03 | 6 | 213 | 2 | IPR003151 | |
| Domain | FATC_dom | 1.88e-03 | 6 | 213 | 2 | IPR003152 | |
| Domain | Aminotran_5 | 1.88e-03 | 6 | 213 | 2 | PF00266 | |
| Domain | PbH1 | 1.88e-03 | 6 | 213 | 2 | IPR006626 | |
| Domain | PIK_FAT | 1.88e-03 | 6 | 213 | 2 | IPR014009 | |
| Domain | FATC | 1.88e-03 | 6 | 213 | 2 | SM01343 | |
| Domain | - | 1.92e-03 | 22 | 213 | 3 | 2.130.10.30 | |
| Domain | FG_GAP | 1.92e-03 | 22 | 213 | 3 | PS51470 | |
| Domain | Reg_chr_condens | 1.92e-03 | 22 | 213 | 3 | IPR000408 | |
| Domain | RCC1/BLIP-II | 2.19e-03 | 23 | 213 | 3 | IPR009091 | |
| Domain | FG-GAP | 2.48e-03 | 24 | 213 | 3 | PF01839 | |
| Domain | FG-GAP | 2.48e-03 | 24 | 213 | 3 | IPR013517 | |
| Domain | ANATO | 2.62e-03 | 7 | 213 | 2 | SM00104 | |
| Domain | APC_su10/DOC_dom | 2.62e-03 | 7 | 213 | 2 | IPR004939 | |
| Domain | DOC | 2.62e-03 | 7 | 213 | 2 | PS51284 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 2.62e-03 | 7 | 213 | 2 | IPR005479 | |
| Domain | ANAPHYLATOXIN_2 | 2.62e-03 | 7 | 213 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 2.62e-03 | 7 | 213 | 2 | PS01177 | |
| Domain | BC-like_N | 2.62e-03 | 7 | 213 | 2 | IPR005481 | |
| Domain | ANAPC10 | 2.62e-03 | 7 | 213 | 2 | PF03256 | |
| Domain | ANATO | 2.62e-03 | 7 | 213 | 2 | PF01821 | |
| Domain | Glyco_hydro/deAcase_b/a-brl | 2.62e-03 | 7 | 213 | 2 | IPR011330 | |
| Domain | CPSase_L_D2 | 2.62e-03 | 7 | 213 | 2 | PF02786 | |
| Pathway | REACTOME_GLUCURONIDATION | 9.77e-06 | 24 | 175 | 5 | MM14599 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 1.05e-05 | 41 | 175 | 6 | M7399 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.21e-05 | 25 | 175 | 5 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 1.21e-05 | 25 | 175 | 5 | MM15820 | |
| Pathway | WP_GLUCURONIDATION | 1.48e-05 | 26 | 175 | 5 | M39404 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.83e-05 | 45 | 175 | 6 | MM15694 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 1.01e-04 | 8 | 175 | 3 | M47872 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.14e-04 | 39 | 175 | 5 | MM15695 | |
| Pathway | WP_ESTROGEN_METABOLISM | 1.41e-04 | 22 | 175 | 4 | MM15888 | |
| Pathway | REACTOME_RND3_GTPASE_CYCLE | 1.63e-04 | 42 | 175 | 5 | M41826 | |
| Pathway | WP_OXIDATIVE_DAMAGE_RESPONSE | 1.63e-04 | 42 | 175 | 5 | MM15945 | |
| Pathway | REACTOME_RND3_GTPASE_CYCLE | 1.63e-04 | 42 | 175 | 5 | MM15677 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 2.37e-04 | 25 | 175 | 4 | M605 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 3.72e-04 | 28 | 175 | 4 | M19580 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 3.81e-04 | 12 | 175 | 3 | MM1368 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CASPASE_ACTIVATORS_AND_CASPASES | 3.81e-04 | 12 | 175 | 3 | M27630 | |
| Pubmed | EPRS1 PPAN HK1 SPTA1 SPTAN1 ATP10B KAT2A ERBIN ACSL4 NRXN3 DST GSPT2 VPS13A ATP11C ATP11A PLXNA2 FBXO15 VIL1 ZSWIM5 SYNE1 KTN1 SLC44A2 HEATR1 NKIRAS2 IFT122 RIMS1 PRKDC ATM SEPTIN10 RPL3 | 1.01e-08 | 1442 | 219 | 30 | 35575683 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | EPRS1 SGSM1 GAPDH OBSCN ITGAE NDUFS2 FREM2 PARP4 DST TRPM3 VPS13A VIL1 RAB25 KTN1 UGT1A9 GSDMC RNF123 ARHGEF33 CCT8 PRKDC ATM | 1.05e-08 | 736 | 219 | 21 | 29676528 |
| Pubmed | 2.27e-08 | 6 | 219 | 4 | 32527940 | ||
| Pubmed | 2.27e-08 | 6 | 219 | 4 | 20297805 | ||
| Pubmed | EPRS1 HK1 ACADL LZTS3 GAPDH SPTA1 SPTAN1 ITGA2 ERBIN NDUFS2 EPS15L1 DST SLC24A2 G3BP2 SORCS2 C4A C4B GNAQ SYNE1 KTN1 NCKIPSD PSD3 INF2 PEBP1 NISCH CCT8 RIMS1 CDC5L RPL3 | 3.21e-08 | 1431 | 219 | 29 | 37142655 | |
| Pubmed | MAN2B1 MYCBP2 ERBIN DST PTPRF RBM19 HERC2 HERC1 WASHC4 PPIL4 RANBP9 DVL3 PRDM4 ASH2L TDP2 EPG5 RNF123 POLI | 4.70e-08 | 591 | 219 | 18 | 15231748 | |
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 5.28e-08 | 7 | 219 | 4 | 8467709 | |
| Pubmed | 5.28e-08 | 7 | 219 | 4 | 27514509 | ||
| Pubmed | 5.28e-08 | 7 | 219 | 4 | 8464825 | ||
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 5.50e-08 | 17 | 219 | 5 | 20639394 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | EPRS1 HK1 ACADL GAPDH SPTA1 SPTAN1 MCCC1 NDUFS2 EPS15L1 DST G3BP2 GNAQ MAN2B2 NCKIPSD AHSA1 ASH2L CCT8 RPL3 | 9.83e-08 | 621 | 219 | 18 | 22794259 |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 1.02e-07 | 19 | 219 | 5 | 23281178 | |
| Pubmed | 1.05e-07 | 8 | 219 | 4 | 20610558 | ||
| Pubmed | 1.05e-07 | 8 | 219 | 4 | 18052087 | ||
| Pubmed | 1.05e-07 | 8 | 219 | 4 | 17179145 | ||
| Pubmed | HDAC9 PARP4 TRPM3 FIG4 NUP210 ATP11A MAN2B2 KTN1 ZNF407 DGKD ATP8B2 SEMA4G ZBTB34 CCT8 ARHGAP28 CDC5L | 1.14e-07 | 493 | 219 | 16 | 15368895 | |
| Pubmed | 1.88e-07 | 9 | 219 | 4 | 22511988 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EPRS1 HK1 ACADL GAPDH MYCBP2 SPTA1 SPTAN1 MCCC1 DST RAB25 SYNE1 KTN1 EPG5 PEBP1 CCT8 PRKDC RPL3 HYDIN MYO16 SORD | 2.32e-07 | 807 | 219 | 20 | 30575818 |
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 30465166 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 29519853 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 19137635 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 12847094 | ||
| Pubmed | 3.12e-07 | 10 | 219 | 4 | 23642732 | ||
| Pubmed | 3.12e-07 | 10 | 219 | 4 | 11465080 | ||
| Pubmed | 3.12e-07 | 10 | 219 | 4 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 3.12e-07 | 10 | 219 | 4 | 22558097 | |
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 3.65e-07 | 24 | 219 | 5 | 24625756 | |
| Pubmed | ACADL UGT3A1 MCCC1 AGXT ASPG UGT1A10 UGT1A8 UGT1A7 UGT1A9 CPS1 | 3.95e-07 | 190 | 219 | 10 | 24816252 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EPRS1 HK1 GAPDH MYCBP2 SPTAN1 MCCC1 ERBIN ACSL4 DST RBM19 HERC2 WASHC4 KTN1 PPIL4 RANBP9 DGKD HEATR1 INF2 CHTF18 FHOD1 CCT8 WDR82 PRKDC CDC5L RPL3 SORD | 4.83e-07 | 1353 | 219 | 26 | 29467282 |
| Pubmed | HDAC9 EPRS1 MYCBP2 SPTAN1 MCF2L2 VPS26C EPS15L1 PTPN13 DST MKLN1 HERC2 WASHC4 SYNE1 RHOBTB3 RANBP9 DVL3 PRDM4 TDP2 SPRYD7 ZNF18 RNF123 NISCH IFT122 PRKDC ATM | 6.53e-07 | 1285 | 219 | 25 | 35914814 | |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 7.28e-07 | 12 | 219 | 4 | 20308471 | |
| Pubmed | 7.28e-07 | 12 | 219 | 4 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 7.28e-07 | 12 | 219 | 4 | 11434514 | |
| Pubmed | EPRS1 MAN2B1 FAM111B WASH6P FREM2 PARP4 DST CASKIN2 C4A C4B COL6A2 RHOBTB3 ASH2L CHTF18 NISCH IFT122 RPL3 | 9.34e-07 | 650 | 219 | 17 | 38777146 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | GAPDH ACSL4 PTPRF FDFT1 RASA4B TAP2 DVL3 HEATR1 CHTF18 ATM RPL3 | 9.76e-07 | 262 | 219 | 11 | 36880596 |
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 19135723 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 17491658 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 25315773 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 12225333 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 17301242 | ||
| Pubmed | Genomic organization and tissue expression of mouse proteasome gene Lmp-2. | 9.81e-07 | 4 | 219 | 3 | 8325639 | |
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 2777798 | ||
| Pubmed | Selectivity of MHC-encoded peptide transporters from human, mouse and rat. | 9.81e-07 | 4 | 219 | 3 | 8107849 | |
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 27098790 | ||
| Pubmed | Two steroid 21-hydroxylase genes are located in the murine S region. | 9.81e-07 | 4 | 219 | 3 | 6095106 | |
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 20525414 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 3856857 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 17581627 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 17558305 | ||
| Pubmed | EPRS1 ACADL LZTS3 GAPDH MYCBP2 SPTAN1 MCCC1 ERBIN NDUFS2 GGT7 EPS15L1 GSPT2 G3BP2 NECTIN1 MKLN1 KTN1 RANBP9 DVL3 PSD3 PEBP1 CCT8 RIMS1 SEPTIN10 | 1.01e-06 | 1139 | 219 | 23 | 36417873 | |
| Pubmed | Differential expression of putative transbilayer amphipath transporters. | 1.05e-06 | 13 | 219 | 4 | 11015572 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 1.05e-06 | 13 | 219 | 4 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 1.05e-06 | 13 | 219 | 4 | 25246029 | |
| Pubmed | 1.46e-06 | 14 | 219 | 4 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 1.46e-06 | 14 | 219 | 4 | 10836148 | |
| Pubmed | 1.46e-06 | 14 | 219 | 4 | 9295054 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 1.46e-06 | 14 | 219 | 4 | 14672974 | |
| Pubmed | PPAN HK1 SPTAN1 PSMB9 VPS26C MCCC1 ERBIN NDUFS2 DST FDFT1 G3BP2 NFKB1 TRAPPC6B NUP210 TAP2 PSAT1 KTN1 RANBP9 XPO4 HEATR1 INF2 CCT8 DHX32 PRKDC ATM CDC5L | 1.54e-06 | 1440 | 219 | 26 | 30833792 | |
| Pubmed | EPRS1 GAPDH MYCBP2 ACSL4 PARP4 EPS15L1 RBM19 NUP210 ATP11A HERC2 TAP2 KTN1 RNF149 CPD HEATR1 CHTF18 NISCH FHOD1 DEF6 IFT122 PRKDC CDC5L ARHGAP45 | 1.54e-06 | 1168 | 219 | 23 | 19946888 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | EPRS1 MAN2B1 MAOA ACADL GAPDH MCCC1 NDUFS2 ACSL4 C1R TAP2 TMEM181 COL6A2 MAN2B2 DSC2 UGT1A10 UGT1A8 UGT1A7 TMED5 PPIL4 UGT1A9 CPD ASH2L INF2 ADAMTS14 CATSPERG RPL3 | 1.77e-06 | 1451 | 219 | 26 | 30550785 |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | HK1 APTX MDM4 CNTROB EPS15L1 CASKIN2 FKBP1A TAP2 ACP7 KTN1 TAF1A CPD NKIRAS2 PRDM4 EPG5 SPRYD7 CHTF18 POLI RPL3 TP73 | 1.91e-06 | 925 | 219 | 20 | 28986522 |
| Pubmed | 2.44e-06 | 5 | 219 | 3 | 19202550 | ||
| Pubmed | 2.44e-06 | 5 | 219 | 3 | 26567335 | ||
| Pubmed | No association of TAP and LMP genetic polymorphism in human brucellosis and its complications. | 2.44e-06 | 5 | 219 | 3 | 20470844 | |
| Pubmed | Proto-oncogene PML controls genes devoted to MHC class I antigen presentation. | 2.44e-06 | 5 | 219 | 3 | 9845074 | |
| Pubmed | 2.44e-06 | 5 | 219 | 3 | 2652811 | ||
| Pubmed | 2.44e-06 | 5 | 219 | 3 | 20565459 | ||
| Pubmed | 2.44e-06 | 5 | 219 | 3 | 15057901 | ||
| Pubmed | 2.44e-06 | 5 | 219 | 3 | 18248301 | ||
| Pubmed | 2.44e-06 | 5 | 219 | 3 | 1453454 | ||
| Pubmed | 2.44e-06 | 5 | 219 | 3 | 19404951 | ||
| Pubmed | 2.44e-06 | 5 | 219 | 3 | 6316336 | ||
| Pubmed | 2.44e-06 | 5 | 219 | 3 | 19148137 | ||
| Pubmed | 2.52e-06 | 233 | 219 | 10 | 37704626 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 2.62e-06 | 16 | 219 | 4 | 19414484 | |
| Pubmed | HK1 MYCBP2 SPTAN1 ERBIN NDUFS2 PTPN13 ERAP2 CASKIN2 FDFT1 NUP210 DHPS VPS13A HERC2 DSC2 SYNE1 KTN1 PSD3 CPD HEATR1 SLC6A8 INF2 NISCH IFT122 ATM CDC5L RPL3 | 2.76e-06 | 1487 | 219 | 26 | 33957083 | |
| Pubmed | EPRS1 PPAN GAPDH SPTAN1 FAM111B RBM19 G3BP2 CPS1 TRIM56 CCT8 PRKDC CDC5L RPL3 | 3.47e-06 | 425 | 219 | 13 | 21081503 | |
| Pubmed | EPRS1 GAPDH SPTAN1 MCCC1 EPS15L1 DST GSPT2 KTN1 DEF6 PRKDC CDC5L SEPTIN10 | 3.47e-06 | 360 | 219 | 12 | 33111431 | |
| Pubmed | MYCBP2 SPTAN1 CNTROB ERBIN ACSL4 PTPN13 PTPRF CASKIN2 FDFT1 NFKB1 NUP210 DHPS VPS13A HERC2 HERC1 PSAT1 PSD3 XPO4 CPD WDR82 CDC5L | 3.49e-06 | 1049 | 219 | 21 | 27880917 | |
| Pubmed | GAPDH MYCBP2 OBSCN PARP4 DST FDFT1 MKLN1 COL6A3 SYNE1 KTN1 ZNF407 DGKD ASH2L XIRP2 | 3.76e-06 | 497 | 219 | 14 | 23414517 | |
| Pubmed | The mouse as a model for the effects of MHC genes on human disease. | 4.22e-06 | 67 | 219 | 6 | 10871872 | |
| Pubmed | 4.37e-06 | 18 | 219 | 4 | 20056724 | ||
| Pubmed | Androgen-dependent hereditary mouse keratoconus: linkage to an MHC region. | 4.86e-06 | 6 | 219 | 3 | 11773012 | |
| Pubmed | Association of TAP and HLA-DM genes with psoriasis in Koreans. | 4.86e-06 | 6 | 219 | 3 | 12648225 | |
| Pubmed | 4.86e-06 | 6 | 219 | 3 | 11737038 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | EPRS1 PPAN GAPDH MYCBP2 FDFT1 G3BP2 DHPS MKLN1 HERC2 HERC1 VIL1 RAB25 FNTB RANBP9 XPO4 HEATR1 PKD1L3 AHSA1 RNF123 PEBP1 RIMS1 CDC5L RPL3 | 7.31e-06 | 1284 | 219 | 23 | 17353931 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MAN2B1 MYCBP2 C19orf47 OBSCN KAT2A ATG2A CNTROB GGT7 EPS15L1 DST PTPRF RBM19 HERC2 HERC1 FNTB ARHGEF10L SLC6A8 INF2 NISCH DEF6 PRKDC | 7.72e-06 | 1105 | 219 | 21 | 35748872 |
| Pubmed | 7.82e-06 | 113 | 219 | 7 | 30352685 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EPRS1 ZHX3 GAPDH MCCC1 ERBIN EPS15L1 PTPN13 DST PSAT1 KTN1 HEATR1 CHAMP1 AHSA1 PEBP1 FHOD1 CCT8 PRKDC CDC5L RPL3 | 8.30e-06 | 934 | 219 | 19 | 33916271 |
| Pubmed | EPRS1 GAPDH MYCBP2 SPTAN1 ERBIN EPS15L1 PTPN13 KTN1 HEATR1 CHAMP1 ASH2L CCT8 PRKDC CDC5L | 1.16e-05 | 549 | 219 | 14 | 38280479 | |
| Pubmed | SARS-CoV-2 NSP12 associates with TRiC and the P323L substitution acts as a host adaption. | 1.16e-05 | 120 | 219 | 7 | 37929963 | |
| Pubmed | 1.23e-05 | 23 | 219 | 4 | 8799160 | ||
| Pubmed | 1.35e-05 | 8 | 219 | 3 | 18694960 | ||
| Pubmed | Molecular genetics of the human MHC complement gene cluster. | 1.35e-05 | 8 | 219 | 3 | 10072631 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | SGSM1 ACSL4 KAT2B FDFT1 G3BP2 NFKB1 SUPT7L DHPS VPS13A ATP11A HERC1 PLXNA2 ATG16L2 PSAT1 MAN2B2 DSC2 RHOBTB3 NKIRAS2 ATP8B2 TRIM56 DEF6 SEPTIN10 | 1.39e-05 | 1242 | 219 | 22 | 30973865 |
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 1.92e-05 | 87 | 219 | 6 | 17148452 | |
| Pubmed | 1.93e-05 | 52 | 219 | 5 | 26633812 | ||
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 2.01e-05 | 9 | 219 | 3 | 20732626 | |
| Pubmed | 2.01e-05 | 9 | 219 | 3 | 1529427 | ||
| Pubmed | VPS26C ATG2A ACSL4 PTPN13 DST FIG4 VPS13A WASHC4 KTN1 CPD LRIG3 INF2 NISCH | 2.12e-05 | 504 | 219 | 13 | 34432599 | |
| Interaction | INSL6 interactions | 5.89e-06 | 25 | 215 | 5 | int:INSL6 | |
| Interaction | UGT1A9 interactions | 8.35e-06 | 13 | 215 | 4 | int:UGT1A9 | |
| Cytoband | 2q37 | 3.62e-07 | 31 | 219 | 5 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 1.15e-04 | 226 | 219 | 7 | chr2q37 | |
| Cytoband | Xp11.1 | 1.35e-04 | 4 | 219 | 2 | Xp11.1 | |
| Cytoband | 8q11 | 3.36e-04 | 6 | 219 | 2 | 8q11 | |
| Cytoband | 2p22-p21 | 6.22e-04 | 8 | 219 | 2 | 2p22-p21 | |
| GeneFamily | ATPase phospholipid transporting | 7.29e-06 | 15 | 159 | 4 | 1210 | |
| GeneFamily | UDP glucuronosyltransferases | 8.21e-06 | 32 | 159 | 5 | 363 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 9.03e-05 | 161 | 159 | 8 | 593 | |
| GeneFamily | Lysine acetyltransferases|ATAC complex|SAGA complex|GCN5 related N-acetyltransferases | 4.15e-04 | 17 | 159 | 3 | 1059 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 4.94e-04 | 18 | 159 | 3 | 1160 | |
| GeneFamily | Tudor domain containing|Spindlin family | 7.55e-04 | 5 | 159 | 2 | 1089 | |
| GeneFamily | Mannosidases alpha class 2 | 7.55e-04 | 5 | 159 | 2 | 1194 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 1.04e-03 | 51 | 159 | 4 | 870 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.57e-03 | 7 | 159 | 2 | 1113 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.66e-03 | 9 | 159 | 2 | 1234 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.72e-03 | 66 | 159 | 4 | 722 | |
| GeneFamily | Fibronectin type III domain containing | 2.94e-03 | 160 | 159 | 6 | 555 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 3.30e-03 | 10 | 159 | 2 | 830 | |
| GeneFamily | Complement system|Sushi domain containing | 3.85e-03 | 36 | 159 | 3 | 492 | |
| GeneFamily | Tudor domain containing | 4.16e-03 | 37 | 159 | 3 | 780 | |
| GeneFamily | ATAC complex | 5.63e-03 | 13 | 159 | 2 | 1058 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | GAPDH MYCBP2 SPTAN1 PSMB8 PSMB9 PTGDR MDM4 ITGAE ERBIN ACSL4 KAT2B ERAP2 G3BP2 NUP210 HERC1 TAP2 CXCR3 SYNE1 KTN1 TMED5 RANBP9 RNF149 XPO4 ATP8B2 TDP2 EPG5 RESF1 FHOD1 DEF6 WDR82 ATM ARHGAP45 | 8.40e-07 | 1492 | 218 | 32 | M40023 |
| Coexpression | GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN | TRPM2 PSMB9 HMBS ERAP2 C1R HERC1 PLXNA2 MAN2B2 NISCH FHOD1 ATM | 1.01e-06 | 200 | 218 | 11 | M3416 |
| Coexpression | DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS | SGSM1 ATP10B PTPN13 NRXN3 PTPRF TRPM3 SORCS2 ADAMTS17 DSC2 SYNE1 CNTN3 ADAMTS14 | 1.05e-06 | 244 | 218 | 12 | M40312 |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_UP | PSMB8 PSMB9 VPS26C ITGA2 G3BP2 ATG16L2 SYNE1 NKIRAS2 SLC16A3 DEF6 | 7.32e-06 | 200 | 218 | 10 | M7295 |
| Coexpression | JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER | 1.97e-05 | 40 | 218 | 5 | M4988 | |
| Coexpression | GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN | 3.23e-05 | 190 | 218 | 9 | M9521 | |
| Coexpression | GSE14308_TH2_VS_NATURAL_TREG_DN | 4.63e-05 | 199 | 218 | 9 | M3369 | |
| Coexpression | GSE17721_0.5H_VS_8H_LPS_BMDC_DN | 4.63e-05 | 199 | 218 | 9 | M4075 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 4.63e-05 | 199 | 218 | 9 | M9124 | |
| Coexpression | GSE19198_1H_VS_6H_IL21_TREATED_TCELL_DN | 4.82e-05 | 200 | 218 | 9 | M7232 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | PSMB8 PSMB9 ERBIN FREM2 PTPRF ERAP2 FIG4 VPS13A C1R C4A C4B ATP11A PLXNA2 DSC2 ASPG DVL3 PKHD1L1 ASH2L SLC16A3 INF2 CNTN3 | 5.24e-05 | 955 | 218 | 21 | M45680 |
| Coexpression | NUYTTEN_EZH2_TARGETS_UP | PSMB8 PSMB9 MGLL CPED1 PTPRF ERAP2 PTX3 SORCS2 C1R GNAQ FKBP1A WASHC4 SYNE1 TMED5 RNF149 SLC44A2 DGKD ZBTB34 SEMA3D RESF1 SLC16A3 ADAMTS14 | 5.54e-05 | 1033 | 218 | 22 | M4196 |
| Coexpression | DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP | HMBS KAT2A CPED1 EPS15L1 FKBP1A COL6A2 RAB25 UGT1A10 NCKIPSD INF2 PRKDC SORD | 6.53e-05 | 368 | 218 | 12 | M16431 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SPTA1 OBSCN FREM2 TRPM3 SLC24A2 USH2A CPS1 PKHD1L1 XIRP2 HYDIN MYO16 | 2.05e-09 | 184 | 219 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SPTA1 OBSCN FREM2 TRPM3 SLC24A2 USH2A CPS1 PKHD1L1 XIRP2 HYDIN MYO16 | 2.05e-09 | 184 | 219 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SPTA1 OBSCN FREM2 TRPM3 SLC24A2 USH2A CPS1 PKHD1L1 XIRP2 HYDIN MYO16 | 2.05e-09 | 184 | 219 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | MYCBP2 NBEAL1 MDM4 CAPN13 PTPN13 RHOBTB3 CPD LRIG3 RIMS1 SORD | 5.82e-08 | 199 | 219 | 10 | 3d01f90ffd271ca00129192787e4921bdca7e01e |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | MYCBP2 NBEAL1 ATP10B CAPN13 PTPN13 RHOBTB3 CPD LRIG3 RIMS1 SORD | 5.82e-08 | 199 | 219 | 10 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.31e-07 | 194 | 219 | 9 | 2172d951896265243d14996eacce5aab5e14e26e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.78e-07 | 196 | 219 | 9 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.78e-07 | 196 | 219 | 9 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / Treatment groups by lineage, cell group, cell type | 6.30e-07 | 198 | 219 | 9 | 655df75b9692d815c7f6910275e1f684ac63bf62 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-epithelial_progenitor_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.30e-07 | 198 | 219 | 9 | e8bfae3888b2406b5629b576cb02913b3297337e | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.57e-07 | 199 | 219 | 9 | 5b140ac88ebc25ce397ae577e48f3e271faf46e7 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.57e-07 | 199 | 219 | 9 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.57e-07 | 199 | 219 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | healthy_donor|World / Disease condition, Lineage, Cell class and subclass | 6.85e-07 | 200 | 219 | 9 | afd4d5609adaa470e3d880f8be4a4d55e162b3d6 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.85e-07 | 200 | 219 | 9 | 0f6620a5baace704518d42fa2f3f90751240f7dd | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.44e-06 | 162 | 219 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 169 | 219 | 8 | 0054f9bfd4d377c7fd94873c1308622051c59a8e | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 169 | 219 | 8 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 2.07e-06 | 170 | 219 | 8 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.16e-06 | 171 | 219 | 8 | fe27bf581c75ef33c2848878e51ed16b275a4c8e | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.16e-06 | 171 | 219 | 8 | 25c1979e972c959e1ce4c57804f976f53a247ad7 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-06 | 174 | 219 | 8 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.87e-06 | 185 | 219 | 8 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.19e-06 | 187 | 219 | 8 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-06 | 188 | 219 | 8 | 40ce7125fca6f6b6b5cc1637c87d43c29b08f4f1 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.36e-06 | 188 | 219 | 8 | ba7f7ce034c0f42742bf2461f68f8d343ee593a5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.36e-06 | 188 | 219 | 8 | 1a751452c0f1f34b3c20fad2fb52c378ab2d0207 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.71e-06 | 190 | 219 | 8 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.09e-06 | 192 | 219 | 8 | 3e1a4cb0d83efd502c8613d41a1692bdda5860ed | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.09e-06 | 192 | 219 | 8 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-06 | 192 | 219 | 8 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-06 | 193 | 219 | 8 | 55f37fdba469bea9869a34c4d4f00cb1a3b7a73f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.29e-06 | 193 | 219 | 8 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.49e-06 | 194 | 219 | 8 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-06 | 195 | 219 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-06 | 195 | 219 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.92e-06 | 196 | 219 | 8 | 153326be031a58b720da4dab57edd8936d513f8e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.92e-06 | 196 | 219 | 8 | b7748618aaf3ace40940be1b6ca2148e941541a2 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 6.14e-06 | 197 | 219 | 8 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.14e-06 | 197 | 219 | 8 | a72047b7428c0d4aaf016c1ac23dc30919260fd8 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.38e-06 | 198 | 219 | 8 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.38e-06 | 198 | 219 | 8 | 53e9ed1b19cb26be58da0f37057caca0cdfaabeb | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.38e-06 | 198 | 219 | 8 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.62e-06 | 199 | 219 | 8 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.62e-06 | 199 | 219 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Mesothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 6.62e-06 | 199 | 219 | 8 | ca970114b5aef4518ce580897a62ac88688b2671 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.62e-06 | 199 | 219 | 8 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.86e-06 | 200 | 219 | 8 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.86e-06 | 200 | 219 | 8 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.86e-06 | 200 | 219 | 8 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 6.86e-06 | 200 | 219 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.86e-06 | 200 | 219 | 8 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.86e-06 | 200 | 219 | 8 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 6.86e-06 | 200 | 219 | 8 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.69e-06 | 145 | 219 | 7 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-05 | 154 | 219 | 7 | 89a94a36dfd3d75e411038f04adaf0bbab17db45 | |
| ToppCell | tumor_Lung-T/NK_cells-Naive_CD8+_T|tumor_Lung / Location, Cell class and cell subclass | 1.71e-05 | 164 | 219 | 7 | a669d3b39dcd219a1973e266765e2f2b114438ef | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 164 | 219 | 7 | 950f87d9dacee45c9004a9bf894543de38f72ee5 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 164 | 219 | 7 | c33910a6d87580902e9e7bd27afe6ea63b5eff8d | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 164 | 219 | 7 | bf0d3ad9016a0b8011a2385bb92f0a4f5edad1d6 | |
| ToppCell | facs-Tongue-nan-24m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 167 | 219 | 7 | 73fdf4b81a45ec686d2929eaf641b434f70b7898 | |
| ToppCell | VE-Treg-exh_CD4|VE / Condition, Cell_class and T cell subcluster | 1.93e-05 | 167 | 219 | 7 | 1036ac1ef9440612500137af9d1929672b077e4d | |
| ToppCell | facs-Tongue-nan-24m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 167 | 219 | 7 | c4157fb31b44fe7c44be4215dda8ae2d37cf49a8 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.00e-05 | 168 | 219 | 7 | d2b91f2adc95dcfa623f8d7ca2df1c6f884da988 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.42e-05 | 173 | 219 | 7 | 36a471576a9d2325066bb14c2f2cd89c67b92915 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-05 | 173 | 219 | 7 | 66f37c1437705734b20601656fa4aa1d92ca30be | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-05 | 173 | 219 | 7 | 649b08a409095592cccf31883be69c754411280d | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.70e-05 | 176 | 219 | 7 | 7b5e50eb144bf43ca0cf354a466eb58b976a79f1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-05 | 176 | 219 | 7 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 178 | 219 | 7 | cd85dcefe94ee742db64b63e105e13532321894a | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.90e-05 | 178 | 219 | 7 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 178 | 219 | 7 | ee674e379ee57e40eb2560ff5ed4c13d8db7ed9d | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.90e-05 | 178 | 219 | 7 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 178 | 219 | 7 | 6c45bf197d6c1be0ef7d3a644c0062acf1e24e4d | |
| ToppCell | facs-Skin-nan-24m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 121 | 219 | 6 | 80c79ce48664f65909ba1d167cc7bfcfedeef520 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.01e-05 | 179 | 219 | 7 | 948c2a01ec7a626c68281e6e796a9f0527a88591 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-05 | 179 | 219 | 7 | 78fae47ec9bff4e0159a86a281e831d7f8ee925a | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.01e-05 | 179 | 219 | 7 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-05 | 180 | 219 | 7 | 8d9be9cfdf98e5888654a28ab12e5e89f201af00 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.23e-05 | 181 | 219 | 7 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-05 | 181 | 219 | 7 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.34e-05 | 182 | 219 | 7 | 42e3d32911d5d5cc14d8391623968af594cf2e5f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.46e-05 | 183 | 219 | 7 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-05 | 183 | 219 | 7 | 85446581999cd66b171c4f69b7eb8b0bbbaa8617 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 183 | 219 | 7 | 24db9cc717e651586317c6a8e03a3401651273c1 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 183 | 219 | 7 | 92ef926e6c1de8477fa4f35d1dae85482d8009de | |
| ToppCell | (7)_Epithelial-H_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.58e-05 | 184 | 219 | 7 | 1f76b37c265b519171b767a52d48f31f0cdc4a3c | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.71e-05 | 185 | 219 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.71e-05 | 185 | 219 | 7 | 44ce50cb99df8ffc50eba311adcf688477618659 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.71e-05 | 185 | 219 | 7 | 17542ccd52a821c9e99b1a7469e80502e764b3fd | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.71e-05 | 185 | 219 | 7 | d685a5a2e525db2eba449cfa1e5cd54eb36162a8 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.71e-05 | 185 | 219 | 7 | 5d8d6fd7800f76ee3aa5cef95241d8e6d7e8db04 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.71e-05 | 185 | 219 | 7 | 100b5afdf3c6ab07ffc493f7883f5a7b31c59184 | |
| ToppCell | COVID-19_Severe-Hematopoietic_R|COVID-19_Severe / Disease group, lineage and cell class | 3.71e-05 | 185 | 219 | 7 | 30f064ab7c3890e6f419a845276b145112e78f52 | |
| ToppCell | PBMC-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.71e-05 | 185 | 219 | 7 | f3b1907c3b6f930bc161f46efce5e143babab507 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.71e-05 | 185 | 219 | 7 | 9878392d79734ab5bb977d7f4f5e2e079b9a5353 | |
| ToppCell | COVID-19_Severe-Hematopoietic_R-RBC|COVID-19_Severe / Disease group, lineage and cell class | 3.71e-05 | 185 | 219 | 7 | 3ed6090b822c6d1d400a421236cddc7511743932 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.84e-05 | 186 | 219 | 7 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-05 | 187 | 219 | 7 | f491ec986dd44e2dabdf4a75c3101e3b6c921872 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-05 | 187 | 219 | 7 | 96dc5dc4dbc1b33c2e66666e9027cfbf7972090b | |
| Drug | naringenin chalcone | 3.98e-08 | 5 | 217 | 4 | ctd:C027329 | |
| Drug | anthrarobin | 3.98e-08 | 5 | 217 | 4 | ctd:C032186 | |
| Drug | N-methylpiperazine | 4.59e-08 | 22 | 217 | 6 | CID000053167 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 1.19e-07 | 6 | 217 | 4 | ctd:C543211 | |
| Drug | alloin | 1.19e-07 | 6 | 217 | 4 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 1.19e-07 | 6 | 217 | 4 | ctd:C107497 | |
| Drug | PCB-61 | 1.40e-07 | 14 | 217 | 5 | CID000036401 | |
| Drug | H-Ni | 2.21e-07 | 28 | 217 | 6 | CID000445665 | |
| Drug | 2',4'-dihydroxychalcone | 2.75e-07 | 7 | 217 | 4 | ctd:C059354 | |
| Drug | 1,4-dihydroxyanthraquinone | 5.45e-07 | 8 | 217 | 4 | ctd:C034890 | |
| Drug | Br 2 | 5.82e-07 | 18 | 217 | 5 | CID003060900 | |
| Drug | N-benzylformamide | 6.47e-07 | 76 | 217 | 8 | CID000080654 | |
| Drug | 9-OH-risperidone | 7.83e-07 | 19 | 217 | 5 | CID000475100 | |
| Drug | AC1MRQNQ | 9.74e-07 | 9 | 217 | 4 | CID003522271 | |
| Drug | DHPASiU | 9.74e-07 | 9 | 217 | 4 | CID000197602 | |
| Drug | 3-iodophenol | 9.74e-07 | 9 | 217 | 4 | CID000012272 | |
| Drug | AC1L4J7U | 9.74e-07 | 9 | 217 | 4 | CID000186631 | |
| Drug | Chebi:32663 | 9.74e-07 | 9 | 217 | 4 | CID005460873 | |
| Drug | anisole | 1.07e-06 | 36 | 217 | 6 | CID000007519 | |
| Drug | Benzamidoxime hydrochloride | 1.35e-06 | 21 | 217 | 5 | CID000069186 | |
| Drug | hydride | CYP2D7 MAOA ACADL GAPDH CYP21A2 ITGA2 MCCC1 NDUFS2 PARP4 FDFT1 DHPS C4A ATP11A FKBP1A SYNE1 SLC44A2 CPS1 SLC16A3 SLC26A7 POLI SLC28A1 RIMS1 NPAS4 SORD | 1.59e-06 | 835 | 217 | 24 | CID000000783 |
| Drug | 2,6-dihydroxyanthraquinone | 1.61e-06 | 10 | 217 | 4 | ctd:C034889 | |
| Drug | plumbagin | 1.73e-06 | 22 | 217 | 5 | ctd:C014758 | |
| Drug | 4-nitrophenyl)imidazole | 2.51e-06 | 11 | 217 | 4 | CID000123155 | |
| Drug | AC1O5XMV | 2.51e-06 | 11 | 217 | 4 | CID006442661 | |
| Drug | 5-hydroxytryptophol | 2.76e-06 | 42 | 217 | 6 | CID000009061 | |
| Drug | hydratropic acid | 3.39e-06 | 4 | 217 | 3 | ctd:C013025 | |
| Drug | 2-vanillin | 3.39e-06 | 4 | 217 | 3 | ctd:C060843 | |
| Drug | diphenylacetic acid | 3.39e-06 | 4 | 217 | 3 | ctd:C037760 | |
| Drug | N-OH-DABZ | 3.74e-06 | 12 | 217 | 4 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 3.74e-06 | 12 | 217 | 4 | CID000088735 | |
| Drug | 4-hydroxyestrone | 3.74e-06 | 12 | 217 | 4 | ctd:C026418 | |
| Drug | 2,4,6-TCB | 3.74e-06 | 12 | 217 | 4 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 3.74e-06 | 12 | 217 | 4 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 3.74e-06 | 12 | 217 | 4 | CID000276709 | |
| Drug | silibinin | GGT7 DST NFKB1 DHPS COL6A2 COL6A3 PSAT1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 PRKDC SORD | 3.82e-06 | 285 | 217 | 13 | CID000005213 |
| Drug | 2-hydroxyestrone | 5.36e-06 | 13 | 217 | 4 | ctd:C024980 | |
| Drug | tritanol | 5.36e-06 | 13 | 217 | 4 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 5.36e-06 | 13 | 217 | 4 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 5.36e-06 | 13 | 217 | 4 | CID000000411 | |
| Drug | alizarin | 5.36e-06 | 13 | 217 | 4 | ctd:C010078 | |
| Drug | propranolol glucuronide | 7.45e-06 | 14 | 217 | 4 | CID000119515 | |
| Drug | scopoletin | 7.83e-06 | 50 | 217 | 6 | CID005280460 | |
| Drug | isovaleric acid | 8.42e-06 | 5 | 217 | 3 | ctd:C008216 | |
| Drug | biphenylylacetic acid | 8.42e-06 | 5 | 217 | 3 | ctd:C012776 | |
| Drug | (+/-)-Abacavir | 8.81e-06 | 51 | 217 | 6 | CID000001971 | |
| Drug | tolcapone | 8.81e-06 | 30 | 217 | 5 | CID004659569 | |
| Drug | dihydroartemisinin | 8.81e-06 | 30 | 217 | 5 | CID000107770 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 1.01e-05 | 15 | 217 | 4 | CID000040469 | |
| Drug | afloqualone | 1.01e-05 | 15 | 217 | 4 | CID000002040 | |
| Drug | naphthyl sulphate | 1.01e-05 | 15 | 217 | 4 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 1.01e-05 | 15 | 217 | 4 | CID000010752 | |
| Drug | bergamottin | 1.01e-05 | 15 | 217 | 4 | ctd:C068337 | |
| Drug | sulforaphane nitrile | 1.01e-05 | 15 | 217 | 4 | CID000543743 | |
| Drug | quercetin-3,4'-diglucoside | 1.34e-05 | 16 | 217 | 4 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 1.34e-05 | 16 | 217 | 4 | CID000040003 | |
| Drug | bilirubin-phosphate | 1.34e-05 | 16 | 217 | 4 | CID005497144 | |
| Drug | R(-)-Denopamine | 1.43e-05 | 33 | 217 | 5 | CID000003818 | |
| Drug | Invader | 1.53e-05 | 56 | 217 | 6 | CID006442259 | |
| Drug | 3-phenylpropionic acid | 1.67e-05 | 6 | 217 | 3 | ctd:C035253 | |
| Drug | Indoprofen | 1.67e-05 | 6 | 217 | 3 | ctd:D007216 | |
| Drug | diosmetin | 1.70e-05 | 85 | 217 | 7 | CID005281612 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 1.73e-05 | 17 | 217 | 4 | CID000003573 | |
| Drug | 6-hydroxychrysene | 1.73e-05 | 17 | 217 | 4 | CID000037766 | |
| Drug | cis isomer | 1.87e-05 | 58 | 217 | 6 | CID006474725 | |
| Drug | SureCN12722713 | 2.21e-05 | 18 | 217 | 4 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 2.21e-05 | 18 | 217 | 4 | CID000152226 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 2.21e-05 | 18 | 217 | 4 | CID000036614 | |
| Drug | ApApG | 2.21e-05 | 18 | 217 | 4 | CID003081975 | |
| Drug | C1 11-32 | 2.21e-05 | 18 | 217 | 4 | CID000443077 | |
| Drug | C11131 | 2.21e-05 | 18 | 217 | 4 | CID000443076 | |
| Drug | 6beta-hydroxytestosterone | 2.55e-05 | 37 | 217 | 5 | CID000065543 | |
| Drug | N-Fg | 2.55e-05 | 37 | 217 | 5 | CID000445227 | |
| Drug | 5alpha-spirostan-3beta-ol | 2.78e-05 | 19 | 217 | 4 | CID000091433 | |
| Drug | almokalant | 2.78e-05 | 19 | 217 | 4 | CID003033962 | |
| Drug | formononetin | 2.92e-05 | 38 | 217 | 5 | ctd:C007768 | |
| Drug | AC1Q6DJO | 3.07e-05 | 93 | 217 | 7 | CID000000630 | |
| Drug | tectochrysin | 3.45e-05 | 20 | 217 | 4 | CID005281954 | |
| Drug | AC1L1OBF | 3.45e-05 | 20 | 217 | 4 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 3.45e-05 | 20 | 217 | 4 | CID000116545 | |
| Drug | entacapone | 3.45e-05 | 20 | 217 | 4 | ctd:C071192 | |
| Drug | harmol | 3.77e-05 | 40 | 217 | 5 | CID000068094 | |
| Drug | cyproheptadine | 3.77e-05 | 96 | 217 | 7 | CID000002913 | |
| Drug | rifampicin | HDAC9 CYP2D7 GAPDH CYP21A2 HMBS KAT2B SPIN2A SPIN2B UGT1A10 UGT1A8 UGT1A7 UGT1A9 | 4.04e-05 | 306 | 217 | 12 | CID005381226 |
| Drug | estriol-16-glucuronide | 4.23e-05 | 21 | 217 | 4 | CID000122281 | |
| Drug | dulcin | 4.23e-05 | 21 | 217 | 4 | CID000009013 | |
| Drug | AC1MRGT8 | 4.30e-05 | 67 | 217 | 6 | CID003517815 | |
| Drug | 2,3-diene | 4.62e-05 | 8 | 217 | 3 | CID000010566 | |
| Drug | glabridin | 4.62e-05 | 8 | 217 | 3 | ctd:C107601 | |
| Drug | L 654969 | 4.79e-05 | 42 | 217 | 5 | CID000005218 | |
| Drug | AC1NFJIQ | 4.79e-05 | 42 | 217 | 5 | CID004659568 | |
| Drug | amonafide | 5.13e-05 | 22 | 217 | 4 | CID000050515 | |
| Drug | MS-222 | 6.03e-05 | 44 | 217 | 5 | CID000011400 | |
| Drug | amidoxime | 6.16e-05 | 23 | 217 | 4 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 6.16e-05 | 23 | 217 | 4 | CID000066651 | |
| Drug | phenanthridine | 6.16e-05 | 23 | 217 | 4 | CID000009189 | |
| Drug | aniline | 6.73e-05 | 142 | 217 | 8 | CID000006115 | |
| Drug | eugenol | 6.99e-05 | 73 | 217 | 6 | CID000003314 | |
| Drug | AS-3201 | 7.34e-05 | 24 | 217 | 4 | CID000153948 | |
| Drug | 7,3'-dihydroxy-4'-methoxyisoflavone | 7.49e-05 | 46 | 217 | 5 | ctd:C121707 | |
| Disease | X-21448 measurement | 4.58e-09 | 10 | 213 | 5 | EFO_0800816 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 1.31e-08 | 5 | 213 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 1.31e-08 | 5 | 213 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 1.31e-08 | 5 | 213 | 4 | EFO_0801853 | |
| Disease | X-21339 measurement | 9.08e-08 | 7 | 213 | 4 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 1.81e-07 | 8 | 213 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 1.81e-07 | 8 | 213 | 4 | EFO_0022118 | |
| Disease | X-11530 measurement | 1.81e-07 | 8 | 213 | 4 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 1.81e-07 | 8 | 213 | 4 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 1.81e-07 | 8 | 213 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 1.81e-07 | 8 | 213 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 1.81e-07 | 8 | 213 | 4 | EFO_0800692 | |
| Disease | X-24849 measurement | 1.81e-07 | 8 | 213 | 4 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 1.81e-07 | 8 | 213 | 4 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 1.81e-07 | 8 | 213 | 4 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 1.81e-07 | 8 | 213 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 1.81e-07 | 8 | 213 | 4 | EFO_0800766 | |
| Disease | X-11442 measurement | 3.23e-07 | 9 | 213 | 4 | EFO_0021236 | |
| Disease | X-11441 measurement | 3.23e-07 | 9 | 213 | 4 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 3.23e-07 | 9 | 213 | 4 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 3.23e-07 | 9 | 213 | 4 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 3.23e-07 | 9 | 213 | 4 | EFO_0801036 | |
| Disease | X-11880 measurement | 3.23e-07 | 9 | 213 | 4 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 3.23e-07 | 9 | 213 | 4 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 3.23e-07 | 9 | 213 | 4 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 3.23e-07 | 9 | 213 | 4 | EFO_0004570, GO_0009410 | |
| Disease | indole-3-carboxylate measurement | 3.71e-07 | 3 | 213 | 3 | EFO_0800043 | |
| Disease | blood 4-oxo-retinoic acid measurement | 3.71e-07 | 3 | 213 | 3 | EFO_0022216 | |
| Disease | bilirubin measurement, response to tenofovir | 5.36e-07 | 10 | 213 | 4 | EFO_0004570, EFO_0009279 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 5.36e-07 | 10 | 213 | 4 | EFO_0802185 | |
| Disease | X-23974 measurement | 5.36e-07 | 10 | 213 | 4 | EFO_0800867 | |
| Disease | pregnenetriol sulfate measurement | 8.37e-07 | 11 | 213 | 4 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 8.37e-07 | 11 | 213 | 4 | EFO_0600039 | |
| Disease | histidine betaine (hercynine) measurement | 8.37e-07 | 11 | 213 | 4 | EFO_0800972 | |
| Disease | X-21796 measurement | 8.37e-07 | 11 | 213 | 4 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 8.37e-07 | 11 | 213 | 4 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 8.37e-07 | 11 | 213 | 4 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 1.25e-06 | 12 | 213 | 4 | EFO_0800079 | |
| Disease | biliverdin measurement | 1.25e-06 | 12 | 213 | 4 | EFO_0021033 | |
| Disease | amino acid measurement, citrulline measurement | 1.48e-06 | 4 | 213 | 3 | EFO_0005134, EFO_0009777 | |
| Disease | neuroblastoma, cutaneous melanoma | 1.61e-06 | 28 | 213 | 5 | EFO_0000389, EFO_0000621 | |
| Disease | pregnenetriol disulfate measurement | 1.79e-06 | 13 | 213 | 4 | EFO_0800587 | |
| Disease | retinol dehydrogenase 16 measurement | 1.79e-06 | 13 | 213 | 4 | EFO_0802007 | |
| Disease | Malignant neoplasm of breast | MAOA SPTAN1 MCF2L2 OBSCN HEPACAM2 MDM4 G3BP2 HERC2 PDZD4 ZSWIM5 SYNE1 KTN1 RNF149 DVL3 UGT1A9 CUBN EPG5 SLC16A3 NISCH SLC28A1 DHX32 ATM TP73 | 3.58e-06 | 1074 | 213 | 23 | C0006142 |
| Disease | lysine measurement, amino acid measurement | 3.67e-06 | 5 | 213 | 3 | EFO_0005002, EFO_0005134 | |
| Disease | urate measurement, spine bone mineral density | 3.90e-06 | 58 | 213 | 6 | EFO_0004531, EFO_0007701 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 5.84e-06 | 17 | 213 | 4 | EFO_0004611, EFO_0007800 | |
| Disease | X-21441 measurement | 5.84e-06 | 17 | 213 | 4 | EFO_0800814 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 7.30e-06 | 6 | 213 | 3 | EFO_0800566 | |
| Disease | angiopoietin-related protein 1 measurement | 7.46e-06 | 18 | 213 | 4 | EFO_0801382 | |
| Disease | amino acid measurement, threonine measurement | 1.27e-05 | 7 | 213 | 3 | EFO_0005134, EFO_0009775 | |
| Disease | gallstones | 1.39e-05 | 108 | 213 | 7 | EFO_0004210 | |
| Disease | tissue factor measurement | 1.43e-05 | 21 | 213 | 4 | EFO_0010623 | |
| Disease | metabolite measurement | CYP2D7 ACADL SPTA1 CYP21A2 UGT3A1 PSMB9 MCCC1 ASPG UGT1A10 UGT1A8 UGT1A7 PSD3 UGT1A9 CPS1 SLC28A1 | 1.54e-05 | 560 | 213 | 15 | EFO_0004725 |
| Disease | mean reticulocyte volume | HDAC9 HK1 SPTA1 C19orf47 KAT2A CPED1 KAT2B PTPRF FDFT1 NFKB1 VPS13A FNTB OR6P1 RESF1 CHTF18 POLI ATM MYO16 | 2.23e-05 | 799 | 213 | 18 | EFO_0010701 |
| Disease | Parkinson disease | LZTS3 MYCBP2 TRPM2 MCCC1 ITGAE FDFT1 RAB25 KTN1 RESF1 RIMS1 SLC41A1 | 2.40e-05 | 321 | 213 | 11 | MONDO_0005180 |
| Disease | 2R,3R-dihydroxybutyrate measurement | 3.02e-05 | 9 | 213 | 3 | EFO_0800314 | |
| Disease | indoleacetate measurement | 4.29e-05 | 10 | 213 | 3 | EFO_0021015 | |
| Disease | cholelithiasis | 4.37e-05 | 88 | 213 | 6 | EFO_0004799 | |
| Disease | obsolete_red blood cell distribution width | HK1 SPTA1 CYP21A2 C19orf47 ITGAD WNT5B FIG4 G3BP2 NUP210 VPS13A ATP11C ATP11A GNAQ HERC1 ZNF407 R3HDM2 CPS1 EPG5 RNF123 RESF1 TRIM56 DHX32 MYO16 SORD | 4.48e-05 | 1347 | 213 | 24 | EFO_0005192 |
| Disease | serum metabolite measurement, glycine measurement | 5.19e-05 | 2 | 213 | 2 | EFO_0005653, EFO_0009767 | |
| Disease | 5-hydroxymethyl-2-furoylcarnitine measurement | 5.19e-05 | 2 | 213 | 2 | EFO_0801053 | |
| Disease | X-24757 measurement | 5.19e-05 | 2 | 213 | 2 | EFO_0800905 | |
| Disease | cinnamoylglycine measurement | 5.19e-05 | 2 | 213 | 2 | EFO_0800962 | |
| Disease | isovalerylglycine measurement | 5.19e-05 | 2 | 213 | 2 | EFO_0800025 | |
| Disease | invasive aspergillosis (is_marker_for) | 5.19e-05 | 2 | 213 | 2 | DOID:0050073 (is_marker_for) | |
| Disease | Nakajo syndrome | 5.19e-05 | 2 | 213 | 2 | C1850568 | |
| Disease | N-acetylaspartic acid measurement | 5.19e-05 | 2 | 213 | 2 | EFO_0801183 | |
| Disease | serum metabolite measurement, creatine measurement | 5.19e-05 | 2 | 213 | 2 | EFO_0005653, EFO_0010472 | |
| Disease | NMMA measurement | 5.19e-05 | 2 | 213 | 2 | EFO_0801206 | |
| Disease | X-17367 measurement | 5.19e-05 | 2 | 213 | 2 | EFO_0800779 | |
| Disease | xanthurenate measurement | 5.44e-05 | 29 | 213 | 4 | EFO_0010551 | |
| Disease | glutamine measurement, amino acid measurement | 5.86e-05 | 11 | 213 | 3 | EFO_0005134, EFO_0009768 | |
| Disease | serum metabolite measurement | ACADL CYP21A2 UGT3A1 MCCC1 CPED1 PARP4 ERAP2 ASPG UGT1A10 UGT1A8 UGT1A7 PSD3 UGT1A9 CPS1 SLCO6A1 TRIM56 DEF6 SLC28A1 MOGAT3 | 6.12e-05 | 945 | 213 | 19 | EFO_0005653 |
| Disease | response to dolutegravir | 6.24e-05 | 30 | 213 | 4 | EFO_0600017 | |
| Disease | red blood cell density measurement | HK1 SPTA1 CYP21A2 KAT2B DST PTPRF TRPM3 SORCS2 ATP11A VIL1 FNTB R3HDM2 CPS1 ATP8B2 SEMA3D POLI SEPTIN10 MYO16 | 7.73e-05 | 880 | 213 | 18 | EFO_0007978 |
| Disease | urinary metabolite measurement | 7.82e-05 | 245 | 213 | 9 | EFO_0005116 | |
| Disease | bilirubin measurement | ZHX3 HK1 SPTA1 CYP21A2 MGLL UGT1A10 UGT1A8 UGT1A7 UGT1A9 ZNF407 DGKD CPS1 | 9.75e-05 | 442 | 213 | 12 | EFO_0004570 |
| Disease | X-24588 measurement | 1.01e-04 | 13 | 213 | 3 | EFO_0800898 | |
| Disease | corneal resistance factor | ZHX3 PRTG ITGA2 KAT2B PTPN13 TRPM3 ADAMTS17 HERC2 COL6A2 COL6A3 ZNF407 SLC16A3 | 1.18e-04 | 451 | 213 | 12 | EFO_0010067 |
| Disease | Adenocarcinoma of lung (disorder) | 1.34e-04 | 206 | 213 | 8 | C0152013 | |
| Disease | vitamin D deficiency | 1.45e-04 | 37 | 213 | 4 | EFO_0003762 | |
| Disease | butyrylglycine measurement | 1.55e-04 | 3 | 213 | 2 | EFO_0800208 | |
| Disease | monocyte chemotactic protein 3 measurement | 1.55e-04 | 3 | 213 | 2 | EFO_0008235 | |
| Disease | X-08988 measurement | 1.55e-04 | 3 | 213 | 2 | EFO_0021207 | |
| Disease | X-25420 measurement | 1.55e-04 | 3 | 213 | 2 | EFO_0800926 | |
| Disease | indolepropionylglycine measurement | 1.55e-04 | 3 | 213 | 2 | EFO_0800089 | |
| Disease | 2-methylserine measurement | 1.55e-04 | 3 | 213 | 2 | EFO_0800087 | |
| Disease | tigloylglycine measurement | 1.55e-04 | 3 | 213 | 2 | EFO_0800121 | |
| Disease | mean corpuscular hemoglobin concentration | HDAC9 ZHX3 HK1 SPTA1 CYP21A2 NDUFS2 KAT2B NFKB1 DHPS VPS13A VIL1 FNTB DVL3 PSD3 CPS1 OR6P1 CHTF18 DHX32 PRKDC MYO16 | 1.62e-04 | 1105 | 213 | 20 | EFO_0004528 |
| Disease | reticulocyte count | EPRS1 HK1 SPTA1 ITGAD KAT2B FDFT1 NFKB1 VPS13A SPIN2A C4B ATP11A HERC1 FNTB RHOBTB3 SLC44A2 OR6P1 NISCH ARHGAP45 MOGAT3 | 2.24e-04 | 1045 | 213 | 19 | EFO_0007986 |
| Disease | serine measurement, amino acid measurement | 2.34e-04 | 17 | 213 | 3 | EFO_0005134, EFO_0009774 | |
| Disease | arabitol measurement, xylitol measurement | 3.08e-04 | 4 | 213 | 2 | EFO_0800148, EFO_0801067 | |
| Disease | glycine measurement, amino acid measurement | 3.08e-04 | 4 | 213 | 2 | EFO_0005134, EFO_0009767 | |
| Disease | gamma-glutamylcitrulline measurement | 3.08e-04 | 4 | 213 | 2 | EFO_0800690 | |
| Disease | Ullrich congenital muscular dystrophy | 3.08e-04 | 4 | 213 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 3.08e-04 | 4 | 213 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 3.08e-04 | 4 | 213 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 3.08e-04 | 4 | 213 | 2 | C0410179 | |
| Disease | urinary sodium to creatinine ratio | 3.08e-04 | 4 | 213 | 2 | EFO_0009883 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GFEIHSMQSVEELGS | 241 | O60488 | |
| VDVAKSVTSGLGYMH | 296 | P49682 | |
| GSEYIMALTTGKHEG | 356 | Q6ZRH7 | |
| VIARHAGYSVVEMNA | 386 | Q8WVB6 | |
| HSITNMEIGGLKIYD | 871 | Q96RT1 | |
| DGYVSGQEVKEIFMH | 291 | Q9UBC2 | |
| GQEVKEIFMHSGLTQ | 296 | Q9UBC2 | |
| GAAVVTVQFEGMHKN | 1596 | Q9HCE0 | |
| DEAVSVTHMVKAGSG | 1011 | Q9HCE6 | |
| EVVKQGMSHGELSSE | 641 | Q99459 | |
| YSGSHMVSVDQGRKV | 601 | Q8NAA4 | |
| YLDKAVIHEMSAQTG | 331 | Q5JVX7 | |
| VTVKGHVEYTMEANE | 1401 | P0C0L5 | |
| LGAQMDHAGTVSVFK | 401 | Q8N9M1 | |
| KHGYEVVDTFTITMG | 926 | A4D0V7 | |
| VMSYITNHGSEEQIK | 141 | P28330 | |
| HMVDGNVSGEFTDLV | 251 | O95433 | |
| HKADMGVNVGIEVSV | 91 | Q9BYG8 | |
| SGVLEVGTMTEYKIH | 366 | Q96L96 | |
| GFTEAMQELSRIQHG | 36 | A8MVX0 | |
| MHTVGEKVIVDFAGS | 241 | Q7Z2E3 | |
| MENGLVSLHAYTVTG | 241 | Q6MZZ7 | |
| QTCVVHYTGMLEDGK | 21 | P62942 | |
| MVLGHEASGTVEKVG | 66 | Q00796 | |
| ADEMDVNIGHEVGYV | 131 | Q7L7V1 | |
| MGETKIIYHLDGQET | 1 | Q92997 | |
| GYVSGFGVMEEKIAH | 591 | P00736 | |
| VEMIQDGHQVSLLSG | 356 | Q9UHL0 | |
| QETIEMVKGGHQTSE | 781 | Q02487 | |
| GKHVTMDQVGTFAGL | 1681 | Q2TAZ0 | |
| MAVGIVIYAGHETKA | 281 | O94823 | |
| GDVVFMNQVVHDGTR | 656 | Q8WXS8 | |
| TLVVADADMVQYHGA | 236 | Q8TE56 | |
| IGDGANDVSMIKTAH | 831 | P98198 | |
| VVGEKGYSMVRASHG | 401 | Q9UBL3 | |
| MGAQEAHIYVKTVAG | 96 | Q96PE5 | |
| NMAVEGDHTSVGILG | 426 | Q6ZS30 | |
| GSHEEIQSIMGYIAA | 1086 | Q6ZS30 | |
| FGMDHNVDQTGKAVI | 211 | Q9Y2K5 | |
| VDMETDHYSNGVGET | 561 | Q96S59 | |
| VEEKSFGGSHVMQVI | 626 | O43374 | |
| FGGSHVMQVIYTDDA | 631 | O43374 | |
| YDHAEATIVVMLVGN | 111 | P57735 | |
| SEVDGQVFQGRMLHV | 461 | Q9Y4C8 | |
| QMVHEEGSLSVLGYS | 186 | Q13258 | |
| VEEKSFGGSHVMQVI | 626 | C9J798 | |
| FGGSHVMQVIYTDDA | 631 | C9J798 | |
| VTSNEQVKGYGTHLM | 581 | Q92830 | |
| IKQMRIIHGSGYSDE | 56 | P50148 | |
| GVHTVFGEVTEGMDI | 121 | Q8WUA2 | |
| GERNVQIEMAHGTTT | 61 | P28062 | |
| DTQQGMYDAVLHVGD | 156 | Q6ZNF0 | |
| KASIAGHMFDVVVIG | 6 | P21397 | |
| VVHVDEKGFLASGSM | 1331 | Q8TEM1 | |
| QDLEFGHSMVQAVGT | 346 | Q92619 | |
| AAVEMYISAGEHVKA | 766 | Q9HBG6 | |
| GSGVAHAQEFAMKSV | 41 | O60299 | |
| HIRQFGALTAEVGDM | 286 | Q9NPP4 | |
| GQSEGERMVVSDFHV | 81 | Q99685 | |
| ILHAAGAQGEMFTVK | 36 | O15151 | |
| VTSNEQVKGYGTHLM | 576 | Q92831 | |
| HMRVAAQGFVVGAVT | 61 | A8MV81 | |
| GALQFEVLMAIVGTH | 336 | O15427 | |
| AGLVVHSSMEQDVGL | 226 | Q86U10 | |
| HLRAQGGEVMEYTTI | 551 | Q6UXM1 | |
| GNVALKDHGTAFTIM | 891 | Q9Y6X6 | |
| GQVMHDEFGEGTVTR | 2221 | O95714 | |
| LTAQSHMYEKTIAEG | 4896 | Q03001 | |
| ESDGQIVTMIHRTGD | 2141 | Q5SZK8 | |
| LTYLTGVHEDMGKQS | 2396 | Q15751 | |
| GIMSQVGREEEHYQE | 1471 | Q9BY66 | |
| GELHGTFMVVDQSRE | 316 | Q96Q04 | |
| GIGMAEFLDKHVTSE | 151 | P37268 | |
| VHMAAVDLLIGGTET | 281 | P08686 | |
| IISMEGTVGDALHYQ | 386 | P38570 | |
| FTGIGDSVMHVEQIL | 346 | Q86YR7 | |
| HVDAGKSTIGGQIMF | 211 | Q8IYD1 | |
| GEYIIAEQIVCEMGH | 906 | O75051 | |
| LTLEMVAEAQHAGGV | 331 | Q9UJ14 | |
| MAQLFIEHIFGGSEV | 96 | Q6IF82 | |
| GTQTDITFEHIMALG | 71 | Q76G19 | |
| HFLVVNMKGNDISSG | 86 | P30086 | |
| VAEGTMVGDHTRLEF | 796 | Q9Y4C0 | |
| LTLMNEHGYGEEEKV | 1551 | Q6ZR08 | |
| YGNHVVGSEMIETQE | 26 | Q9NYR9 | |
| MAGTSGSEEVKVLEH | 1106 | Q86UP2 | |
| EAGIHGLVSMTFKVE | 206 | Q6P587 | |
| EVHTGTTIMAVEFDG | 16 | P28065 | |
| AVTQGHGAYLMSQDA | 696 | Q9UKK3 | |
| MTQKTYSDSELGHVG | 296 | Q6PEW0 | |
| IMQGTGEELFDHIVS | 566 | P19367 | |
| KVMVVVTDGESHDGS | 276 | P17301 | |
| HKQLVSSGYDSMGLV | 576 | Q8WXE0 | |
| RVSGGVDMSSHQEVF | 261 | Q27J81 | |
| DQGMEAGIHYVEAVF | 166 | Q9H7L2 | |
| GHMLADVVAIIGTQD | 441 | O75306 | |
| AVVIMVGGAHEALYS | 186 | Q86VF5 | |
| YHLDQKSMTGIAVGV | 941 | Q2VWP7 | |
| VSGEMYTLEHNDGSQ | 1401 | Q86UR5 | |
| HQEMDIVFLIDGSGS | 146 | Q13349 | |
| EDSGLMVFKAEGVHT | 2141 | Q5VST9 | |
| VVGGTDSSMDVFHLE | 41 | O15350 | |
| GHSMVDLVAQGDSIY | 106 | Q8IUM7 | |
| MRNLSGGHVEEFVLV | 1 | Q8NGX9 | |
| TFMKIFGNDNIVGTH | 1846 | O60494 | |
| TMEIKVDHTGEYGNL | 2666 | Q13315 | |
| ENVDAMGVHTGDSVV | 651 | P31327 | |
| ELLDMGETTHQKFSG | 76 | Q4G0P3 | |
| GGKEYIMEHVDLSIN | 206 | Q8NCQ5 | |
| MADIGGHAIYKVEDT | 116 | Q92562 | |
| FRGTDYENVQIHMGT | 21 | Q96JM3 | |
| DAHATLSDGVVVQVM | 81 | Q9UN86 | |
| QHNMVDVLVTTAGGV | 121 | P49366 | |
| EVLSHISNMSYIGGT | 101 | P12111 | |
| DVTVTAIGIGDMFHE | 751 | P12110 | |
| GVHDRAYVMVDGVFQ | 436 | Q6UWU2 | |
| QVKLVGNMHGDETVS | 131 | O75976 | |
| GVGRDTLSMAIHEVY | 196 | Q9H4E7 | |
| SEKEQISSGHNMVEG | 246 | Q9UH90 | |
| VGAGTVEFIMDSKHN | 316 | Q96RQ3 | |
| VMNDEAATHYGAIVD | 156 | O00754 | |
| AATHYGAIVDQMTLG | 161 | O00754 | |
| EFVIGGQVMHDEAVT | 106 | Q9Y2E5 | |
| MDQFGQAAGVLIHSI | 981 | Q16760 | |
| GGLLEDHFETTVKMS | 246 | Q6P179 | |
| FLMHVGGEVDVRSAY | 191 | P49356 | |
| IHAYKGVLMVGNETT | 176 | Q8IWA5 | |
| GVLMVGNETTYEDGH | 181 | Q8IWA5 | |
| EYVGNMTLTCHVEGG | 161 | A8MVW5 | |
| HVTGEETEGMDGQIY | 361 | Q9H583 | |
| MVLVSAGFDALEGHT | 906 | Q9UKV0 | |
| AVHTAMKDGQLYLTG | 266 | P08397 | |
| VDGMLGVVAHSDTIQ | 191 | Q9Y613 | |
| VYEEKTIDGHINLGM | 131 | Q6SJ93 | |
| SHVIQKLGTGNYDVM | 391 | Q9UNA4 | |
| YMGSFEEGEKHQSVS | 111 | Q58EX2 | |
| DMDRIFGIHSENGSI | 426 | Q9ULB4 | |
| AAGEIITASQHGEMV | 536 | Q8IZU8 | |
| ITASQHGEMVFVSGE | 541 | Q8IZU8 | |
| HGEMVFVSGEAVSAY | 546 | Q8IZU8 | |
| HSGKYVCMVQTGVDS | 571 | Q9P232 | |
| DGSKHIFEMESVRGQ | 91 | Q8N137 | |
| VTVKGHVEYTMEANE | 1401 | P0C0L4 | |
| SITQEVAMGTGHVDV | 331 | Q9UKN5 | |
| IHYVNGVSTQGMTLE | 1931 | Q12923 | |
| ILYNGQSVEVDGHSM | 1046 | P10586 | |
| NGELAATTVEMATGH | 286 | P26022 | |
| MSIHIVALGNEGDTF | 1 | O94955 | |
| TIIMEFGGNVTLHQV | 136 | P00540 | |
| HGAETVLSEGMATQQ | 4776 | O75445 | |
| VSYVIDHFDIEIMGG | 336 | P21549 | |
| VATTAGLYGSNLMEH | 61 | P07814 | |
| LETIEVKGAGMTEHY | 3446 | Q8NF91 | |
| VKGAGMTEHYVTQLE | 3451 | Q8NF91 | |
| SVHSAEEIEGKVQGM | 846 | Q8NDG6 | |
| AHQVGETIGISEEIM | 521 | Q9UI40 | |
| RGGHQMVIDVQTETV | 271 | Q9UL63 | |
| VHYGEVTNDFVMLKG | 321 | P39023 | |
| VMHNYESSGINITKG | 741 | Q9HCM1 | |
| EEVETSVLSGAGMHF | 16 | Q15573 | |
| VFTTMEKAGAHLQGG | 101 | P04406 | |
| DNFGIVEGLMTTVHA | 166 | P04406 | |
| DYKGVGISVLEMSHR | 31 | Q9Y617 | |
| GDETLVMTVFGHISF | 616 | Q96PQ0 | |
| VGLLMGISHQEEVFA | 1631 | Q7Z443 | |
| DGIVVVESGHMTLEN | 486 | Q9BZQ2 | |
| MFVGVARHSGSQDEV | 1 | Q86UG4 | |
| EMEHGIYTDVGEKGS | 591 | Q03519 | |
| FGTVAAGMVLDIVQH | 111 | Q8IVJ1 | |
| NTIIGKAVEHMFEGE | 126 | Q99865 | |
| HSVVLMENGDVYTFG | 951 | O75592 | |
| SILGFMAAEQGVHIS | 361 | P48029 | |
| MEQVFHEVGIGSVLS | 216 | O94864 | |
| MSTVVELNVGGEFHT | 31 | Q9BQ13 | |
| ADMVIEAYGHGQRTF | 51 | O94903 | |
| VMVQINTSGEESKHG | 141 | O94903 | |
| DTQHMGTDVVIVKNG | 31 | Q5W111 | |
| IEAVHNTAMRDGGKY | 71 | Q9NZQ3 | |
| HVIAEDGQYDVMFLG | 456 | O95025 | |
| GANDVSMILEAHVGI | 826 | P98196 | |
| ANDVSMILESHVGIG | 821 | Q8NB49 | |
| GVTHMTSRDIEVQGF | 391 | A0A087X1C5 | |
| GGDVKTVRYMFETQH | 511 | A4UGR9 | |
| AVMAGSSGEQKTDIH | 1776 | A4UGR9 | |
| SHAGTGNIVVIMISY | 151 | Q8NC42 | |
| GVASGMKHVETNSYD | 121 | P09327 | |
| FVTHGGQNSVMEAIR | 366 | Q6NUS8 | |
| IAIDAAAGGMTHSQL | 986 | Q9P217 | |
| VLGGFAHMDTETKQQ | 756 | Q9C0E2 | |
| VYGEVSMGQSSLNRH | 106 | P52737 | |
| KTDLDIAVHMTYNTG | 2191 | Q96RL7 | |
| EHGIVVFSLGSMVSE | 296 | Q9HAW8 | |
| SDGVHTVETEVGDYM | 91 | Q9Y3A6 | |
| SQFIMIGSEDGKIHV | 251 | Q6UXN9 | |
| LGSGMHIIEETQVFR | 461 | Q9NTN9 | |
| VQEGVGEGKVMFHSF | 286 | Q9NQ55 | |
| KVDGVAQDGTTMYIH | 236 | Q9P2C4 | |
| SVHQQLGKMVGVSDD | 761 | Q5XPI4 | |
| TVFRMGSEGHQDIDL | 451 | Q9HCF6 | |
| HTGVMKQVGEAVRDF | 211 | O94759 | |
| MEVEDSGGVVLTAYH | 1 | Q9P2N2 | |
| NTIIGKAVEHMFEGE | 126 | Q9BPZ2 | |
| GNLMISEGHFASETI | 106 | Q13813 | |
| HNEMVSGVYKSAEQG | 11 | Q86SZ2 | |
| TLVFDDVQGHDLMGS | 1431 | Q9Y2I1 | |
| ITGHEEGYFTAIMLK | 171 | O95551 | |
| QEHMAYIGEGAKTGI | 66 | Q9H1J7 | |
| EMIEGGHYASDNVTT | 646 | P02549 | |
| VVGSGFSENMEDVHI | 2111 | Q86WI1 | |
| LGHYQFGMTETERKE | 631 | Q2NKQ1 | |
| EHGIVVFSLGSMVSE | 296 | O60656 | |
| ENIRSLTMSGHVGFE | 36 | Q9P0V9 | |
| VMLGRHNVTDVAFGF | 251 | Q8IY26 | |
| SEVHVVMTGGYATIA | 336 | O00337 | |
| SIGFNIGDVQVMAHL | 1381 | P78527 | |
| TTGVHFQTMYEHLGE | 181 | Q2M389 | |
| SANVMYKIGDLGHAT | 371 | P0C1S8 | |
| LETYGKMVSGAGISH | 241 | P17022 | |
| GVTQVVVSEEGAVHM | 2101 | Q9C0G0 | |
| TNMENTYGLEVVGHI | 276 | Q8TE54 | |
| VVTGGKVADMALHYA | 291 | P50990 | |
| AVHKGMGDTYSEVSE | 911 | Q9H4I2 | |
| HQDILSVSADGGIVM | 501 | Q9NYI0 | |
| GAVTKTHVMLGAETE | 176 | Q9NQA3 | |
| EHGIVVFSLGSMVSE | 296 | Q9HAW7 | |
| SVAGHVEVYNMEGSL | 606 | Q9BRZ2 | |
| KDSVQHQGVSLTMEG | 31 | O14972 | |
| GYHTEMVDGEQVVAV | 256 | Q8NCN2 | |
| EHGIVVFSLGSMVSE | 296 | Q9HAW9 | |
| DMVVGFANLGILHVT | 131 | P19838 | |
| NDSMYGFIGTDVVLH | 36 | Q15223 |